02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HEPATOLOGY, VOLUME 62, NUMBER 1 (SUPPL) AASLD ABSTRACTS 1125A<br />

between first and last LSM was 51 months (4-106). Median<br />

basal LSM was similar in treated and nontreated or between<br />

SVR and N-SVR. Fibrosis regression was observed in treated -<br />

49,2% vs NT-36,8% (p=0,30), SVR – 71% vs N-SVR- 26,7%<br />

(p=0.002). Analyzing the final LSM, the SVR group had a<br />

significant increase of the number of patients with stage < F2<br />

(plus 35,6%, p =0.001), in comparison to N-SVR (minus 6.4%,<br />

p ns). During follow-up, a significant decrease of median LSM<br />

was observed in SVR (from 6.55 to 5.55 kPa, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!